Elanco Animal Health (ELAN) Non Operating Income (2017 - 2024)
Elanco Animal Health (ELAN) reported Non Operating Income of -$1.0 million for Q3 2024, up 88.89% on a YoY basis from -$529411.8 in Q4 2023, and up 50.0% sequentially from -$2.0 million in Q2 2024.
Elanco Animal Health (ELAN) Non Operating Income (2017 - 2024) Analysis & Trends
Elanco Animal Health (ELAN) has 8 years of Non Operating Income data on file, last reported at -$1.0 million in Q3 2024.
- For the quarter ending Q3 2024, Non Operating Income rose 88.89% year-over-year to -$1.0 million; the trailing twelve-month figure through Sep 2024 stood at -$46.0 million (up 25.81% YoY), and the FY2023 full-year result was -$75.0 million, down 134.38% from the prior year.
- Non Operating Income grew to -$1.0 million in Q3 2024, from -$2.0 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $115.0 million in Q3 2020 to a low of -$34.0 million in Q4 2023.
- A 5-year average of $3.0 million and a median of -$5.0 million in 2022 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income jumped 1330.77% in 2020 and sank 800.0% in 2022, its largest moves.
- Tracing ELAN's Non Operating Income over 5 years: stood at $16.0 million in 2020, then sank by 81.25% to $3.0 million in 2021, then slumped by 800.0% to -$21.0 million in 2022, then sank by 61.9% to -$34.0 million in 2023, then surged by 97.06% to -$1.0 million in 2024.
- Business Quant data shows ELAN's Non Operating Income at -$1.0 million in Q3 2024, -$2.0 million in Q2 2024, and -$9.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -7.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -13.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -9.00 Mn |
| Dec 31, 2023 | -34.00 Mn |
| Sep 30, 2023 | -9.00 Mn |
| Jun 30, 2023 | -23.00 Mn |
| Mar 31, 2023 | -9.00 Mn |
| Dec 31, 2022 | -21.00 Mn |
| Sep 30, 2022 | -8.00 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Mar 31, 2022 | -9.00 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | -11.00 Mn |
| Jun 30, 2021 | 3.00 Mn |
| Dec 31, 2020 | 16.00 Mn |
| Sep 30, 2020 | 115.00 Mn |
| Jun 30, 2020 | 48.00 Mn |
| Mar 31, 2020 | -1.00 Mn |
| Dec 31, 2019 | -6.90 Mn |
| Sep 30, 2019 | -14.60 Mn |